Polaroid Therapeutics

Polaroid Therapeutics is a Swiss-based biotech start-up in the development of innovative antimicrobial technology. Incubated and developed by Polaroid—the brand that pioneered the complex chemistry and technology behind analog instant photography. Polaroid Therapeutics’ mission is to create human centric medical solutions based on its advancements in science and technology. Founded in 2022, PTx has developed APT™ (Antimicrobial Polymer Technology), a platform that enables controlled antimicrobial performance through structural design rather than chemical release. APT™ integrates proprietary polymer chemistry that can be adapted across multiple formats and clinical contexts, reflecting the company’s focus on responsible innovation, regulated evidence, and long-term antimicrobial resistance (AMR) stewardship.